- Home
- BMRN vs FTAIM Comparison
BMRN vs FTAIM Comparison
Compare BMRN & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- FTAIM
- Stock Information
- Founded
- BMRN 1996
- FTAIM N/A
- Country
- BMRN United States
- FTAIM United States
- Employees
- BMRN N/A
- FTAIM 170
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- FTAIM Misc Corporate Leasing Services
- Sector
- BMRN Health Care
- FTAIM Industrials
- Exchange
- BMRN Nasdaq
- FTAIM Nasdaq
- Market Cap
- BMRN 13.7B
- FTAIM N/A
- IPO Year
- BMRN 1999
- FTAIM N/A
- Fundamental
- Price
- BMRN $70.52
- FTAIM $26.18
- Analyst Decision
- BMRN Buy
- FTAIM
- Analyst Count
- BMRN 22
- FTAIM 0
- Target Price
- BMRN $94.00
- FTAIM N/A
- AVG Volume (30 Days)
- BMRN 1.6M
- FTAIM N/A
- Earning Date
- BMRN 04-23-2025
- FTAIM N/A
- Dividend Yield
- BMRN N/A
- FTAIM N/A
- EPS Growth
- BMRN 153.71
- FTAIM N/A
- EPS
- BMRN 2.21
- FTAIM N/A
- Revenue
- BMRN $2,853,915,000.00
- FTAIM N/A
- Revenue This Year
- BMRN $12.23
- FTAIM N/A
- Revenue Next Year
- BMRN $9.90
- FTAIM N/A
- P/E Ratio
- BMRN $31.97
- FTAIM N/A
- Revenue Growth
- BMRN 17.97
- FTAIM N/A
- 52 Week Low
- BMRN $60.63
- FTAIM N/A
- 52 Week High
- BMRN $94.85
- FTAIM N/A
- Technical
- Relative Strength Index (RSI)
- BMRN 59.12
- FTAIM 46.69
- Support Level
- BMRN $69.89
- FTAIM $25.98
- Resistance Level
- BMRN $73.51
- FTAIM $26.85
- Average True Range (ATR)
- BMRN 2.04
- FTAIM 0.18
- MACD
- BMRN 0.16
- FTAIM -0.04
- Stochastic Oscillator
- BMRN 52.81
- FTAIM 22.26
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate strong and stable cash flows with the potential for earnings growth and asset appreciation.